Canaccord Genuity Reiterates a 'Buy' on NuVasive (NUVA); Raising PT on Continued Growth Across All Business Segments
Get Alerts NUVA Hot Sheet
Price: $39.75 --0%
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on NuVasive (NASDAQ: NUVA) price target raised from $21 to $27.
Analyst, William J. Plovanic, said, "We reiterate our rating on NuVasive following a strong quarter that offered signs that robust top-line growth is still possible with a stabilizing macro spine backdrop. NuVasive handily beat revenue expectations across all business segments, likely taking share. Additionally, we believe integration synergies, international expansion, and new product launches provide upside to our current expectations."
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $16.57 yesterday.
Analyst, William J. Plovanic, said, "We reiterate our rating on NuVasive following a strong quarter that offered signs that robust top-line growth is still possible with a stabilizing macro spine backdrop. NuVasive handily beat revenue expectations across all business segments, likely taking share. Additionally, we believe integration synergies, international expansion, and new product launches provide upside to our current expectations."
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $16.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Deere (DE) PT Raised to $585 at JPMorgan
- DA Davidson Starts Comfort Systems USA (FIX) at Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share